Abstracts Archive - Page 2526 of 2605 - ACR Meeting Abstracts

Abstract Number: 1148 • 2012 ACR/ARHP Annual Meeting
Adalimumab – Effective Control under Refractory JIA Associated Uveitis
Ekaterina Alekseeva¹, Elena Mitenko², Tatyana Bzarova², Saniya Valieva², Kseniya Isayeva², Alexandra Chomakhidze², Evgeniya Chistyakova², Tatyana Sleptsova² and Rina Denisova², ¹PRINTO, Genoa, Italy, ²Rheumatology, Scientific Center of Children's Health, Moscow, Russia
Background/Purpose: Treatment of juvenile idiopathic arthritis (JIA)–associated uveitis is one of the serious problems of paediatric rheumatology. JIA associated uveitis often is refractory to MTX,…
Abstract Number: 1149 • 2012 ACR/ARHP Annual Meeting
Long-Term Safety of Etanercept in Patients with Juvenile Idiopathic Arthritis (JIA)
Kirsten Minden¹, Martina Niewerth², Jens Klotsche³, Michael Hammer⁴, Johannes Peter Haas⁵, Gerd Ganser⁶ and Gerd Horneff⁷, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany, ²Epidemiology, German Rheumatism Research Centre, Berlin, Germany, ³Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany, ⁴Klinik fuer Rheumatologie, St. Josef-Stift, Sendenhorst, Germany, ⁵German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany, ⁶Pediatric Rheumatology, Sankt Josef Stift, Sendenhorst, Germany, ⁷Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany
Background/Purpose: Etanercept (Eta) has been the most frequently used biologic drug in patients with JIA. In Germany, about one in three patients with polyarticular JIA…
Abstract Number: 1150 • 2012 ACR/ARHP Annual Meeting
Adverse Events in Juvenile Idiopathic Arthritis: Results From the Enhanced Drug Safety Surveillance (EDSS) Pilot Project
Sarah Ringold¹, Audrey F. Hendrickson², Carol A. Wallace³ and Rachel E. Sobel⁴, ¹Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, ²Rheumatology, Seattle Children's Research Institute, Seattle, WA, ³Pediatrics, Seattle Childrens Hospital, Seattle, WA, ⁴Epidemiology, Worldwide Safety Strategy, Pfizer, Inc., New York, NY
Background/Purpose: There are few data available regarding the rates of serious and important medical events (SAEs and IMEs) for most of the medications used to…
Abstract Number: 1151 • 2012 ACR/ARHP Annual Meeting
Low-Dose Methotrexate and the Selective Accumulation of Intracellular Aminoimidazolecarboxamide Ribotide
Ryan S. Funk¹, Leon van Haandel¹, Mara L Becker² and J.S. Leeder¹, ¹Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospital, Kansas City, MO, ²Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO
Background/Purpose: Current evidence suggests that the anti-folate methotrexate (MTX) mediates its anti-inflammatory effects through inhibition of the purine synthesis pathway causing the accumulation of…
Abstract Number: 1152 • 2012 ACR/ARHP Annual Meeting
Improvement in Health-Related Quality of Life for Children with Juvenile Ideopathic Arthritis After Start of Treatment with Etanercept
Jens Klotsche¹, Kirsten Minden² and Gerd Horneff³, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany, ²Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany, ³Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany
Background/Purpose: The concept of Health-related quality of life (HrQoL) has been widely accepted as a burden of disease measure in recent years. The improvement in…
Abstract Number: 1153 • 2012 ACR/ARHP Annual Meeting
Perceived Health-Related Quality of Life and Its Determining Factors in Children with Recent-Onset JIA
Jens Klotsche¹, Ina Liedmann¹, Martina Niewerth², Gerd Horneff³, Johannes Peter Haas⁴ and Kirsten Minden⁵, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany, ²Epidemiology, German Rheumatism Research Centre, Berlin, Germany, ³Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany, ⁴German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany, ⁵Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany
Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease and a major cause of chronic disability in children aged below 16 years.…
Abstract Number: 1154 • 2012 ACR/ARHP Annual Meeting
Impact of FokI VDR and TNFalpha–308 Polymorphism On Disease Severity and Long Term Outcome in JIA Patients On Anti-TNF Treatment
Jelena Vojinovic¹, Jelena Basic², Gordana Susic³, Dragana Lazarevic⁴ and Nemanja Damjanov⁵, ¹Dept Pediatric Rheumatology, Clinical Center, School of Medicine University of Nis, Nis, Serbia, ²Institute of Biochemistry, School of Medicine University of Nis, Dr, Nis, Serbia, ³Istituto Giannina Gaslini, Genoa, Italy, ⁴Dept Pediatric Rheumatology, Clinical Center, School of Medicine University of Nis, Dr, Nis, Serbia, ⁵Institute for Rheumatology, University of Belgrade, Prof, Belgrade, Serbia
Background/Purpose: Genetic contribution of SNP (single nucleotide polymorphism) of TNFα–308 promoter and FoxI for VDR (vitamin D receptor) polymorphism on disease severity and outcome in…
Abstract Number: 1155 • 2012 ACR/ARHP Annual Meeting
A New Measure of Visual Function for Children with Juvenile Idiopathic Arthritis-Associated Uveitis
Sheila T. Angeles-Han¹, Steven Yeh², Courtney McCracken¹, Larry B. Vogler³, Kelly A. Rouster-Stevens⁴, Christine W. Kennedy⁵, Kirsten Jenkins⁶, Matthew Kent³, Scott Lambert⁷, Carolyn Drews-Botsch⁸ and Sampath Prahalad⁹, ¹Emory University School of Medicine, Atlanta, GA, ²Ophthalmology, Emory University School of Medicine, Atlanta, GA, ³Dept of Pediatrics, Emory Univ School of Medicine, Atlanta, GA, ⁴Pediatric Rheumatology, Emory Univ School of Medicine, Atlanta, GA, ⁵Rheumatology Immunology, Emory Children's Center, Atlanta, GA, ⁶Children's Healthcare of Atlanta, Atlanta, GA, ⁷Ophthalmology, Emory Univ School of Medicine, Atlanta, GA, ⁸Epidemiology, Emory University School of Public Health, Atlanta, GA, ⁹Pediatrics, Emory Children's Center, Atlanta, GA
Background/Purpose: Studies on outcomes of children with juvenile idiopathic arthritis-associated uveitis (JIA-U) focus on the clinical ocular exam and physical disability secondary to arthritis. This…
Abstract Number: 1116 • 2012 ACR/ARHP Annual Meeting
Diagnostic Value of Internal Rotation Measurement in Patients with Cam- and Pincer-Type Deformities of the Hip
Stephan Reichenbach¹, Michael Leunig², Stefan Werlen³, Andreas Limacher¹, Christian W. Pfirrmann⁴, Reinhold Ganz⁵ and Peter Jüni¹, ¹University of Bern, Bern, Switzerland, ²Schulthess Clinic, Zurich, Switzerland, ³Hospital Sonnenhof, Bern, Switzerland, ⁴Balgrist University Hospital, Zurich, Switzerland, ⁵Department of Orthopedic Surgery, University of Bern, Bern, Switzerland
Background/Purpose: It has been proposed that femoroacetabular impingement (FAI) causes early osteoarthritis (OA) in non-dysplastic hips. FAI occurs predominantly in two different types, ”cam” or…
Abstract Number: 1117 • 2012 ACR/ARHP Annual Meeting
Association Between Hip Bone Marrow Lesions (BMLs) and Bone Mineral Density: A Cross-Sectional and Longitudinal Population-Based Study
Harbeer Ahedi¹, Dawn Dore¹, Leigh Blizzard², Flavia Cicuttini³ and Graeme Jones⁴, ¹Musculoskeletal Unit, Menzies Research institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ²Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, ³Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia, ⁴Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia
Background/Purpose: Bone marrow lesions (BMLs) have been identified one of the key pathologic features in knee osteoarthritis (OA) 1. However, there is limited data on…
Abstract Number: 1118 • 2012 ACR/ARHP Annual Meeting
Association Between Hip and Knee Cartilage Measured Using Radiographs and Magnetic Resonance Imaging: The Tasmanian Older Adult Cohort Study
Hussain Ijaz Khan¹, Dawn Dore², Guangju Zhai³, Changhai Ding⁴, Jean Pierre Pelletier⁵, Johanne Martel-Pelletier⁶, Flavia Cicuttini⁷ and Graeme Jones⁸, ¹Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ²Musculoskeletal Unit, Menzies Research institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ³Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, ⁴Musculoskeletal and Epidemilogy, Menzies research institute & Monash University, Hobart, Australia, ⁵Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, ⁶Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ⁷Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia, ⁸Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia
Background/Purpose: Cartilage loss is the key pathological feature of osteoarthritis (OA) and can be assessed indirectly using radiography or directly through magnetic resonance imaging…
Abstract Number: 1119 • 2012 ACR/ARHP Annual Meeting
Prediction of MRI-Detected Cartilage Loss Over 30 Months Using Simplified Radiographic and Clinical Stratification: The MOST Study
Frank Roemer¹, David T. Felson², Jingbo Niu³, Yuqing Zhang², Michael C. Nevitt⁴, Michel Crema⁵, Cora E. Lewis⁶, James Torner⁷ and Ali Guermazi⁵, ¹Klinikum Augsburg, Augsburg, Germany, ²Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁴Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁵Boston University, Boston, MA, ⁶Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, ⁷Epidemiology, University of Iowa, Iowa City, Iowa City, IA
Background/Purpose: MRI-detected cartilage loss is the main structural outcome measure in large studies of knee OA. Definition of subjects at high risk for cartilage loss…
Abstract Number: 1120 • 2012 ACR/ARHP Annual Meeting
Cartilage Volume Loss Occurs in Most Older Adults and the Rate of Loss Increases with Age
Andreea M. Harsanyi¹, Dawn Dore², Changhai Ding³, Jean-Pierre Pelletier⁴, Johanne Martel-Pelletier⁴, Flavia Cicutinni⁵ and Graeme Jones³, ¹Menzies Research Institute Tasmania, Hobart, Australia, ²Musculoskeletal Unit, Menzies Research institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ³Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ⁴Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ⁵Department of Epidemiology and Preventive Medicine, Monash University, Monash University, Melbourne, Australia, Melbourne, Australia
Background/Purpose: Radiographic data suggests knee osteoarthritis is a relatively static disease even over the long term. It is uncertain how much this is influenced by…
Abstract Number: 1121 • 2012 ACR/ARHP Annual Meeting
Degenerative Medial Meniscal Pathology May Initiate in the Posterior Horn: Data From the Osteoarthritis Initiative
Robert J. Ward¹, Jeffrey B. Driban², Eric E. Wong¹, Jonathan W. Pack¹, Kunal K. Kothari³, Grace H. Lo⁴ and Timothy E. McAlindon⁵, ¹Radiology, Tufts Medical Center, Boston, MA, ²Rheumatology, Tufts Medical Center, Boston, MA, ³Radiology, Tufts University School of Medicine, Boston, MA, ⁴Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, ⁵Division of Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Meniscal pathology is highly prevalent in knee Osteoarthritis (OA). However, details regarding the distribution of pathology within the meniscus has yet to be described…
Abstract Number: 1122 • 2012 ACR/ARHP Annual Meeting
Identifying Radiographic Phenotypes of Early Knee Osteoarthritis Using Separate Quantitative Features Might Improve Patient Selection for More Targeted Treatment
Margot B. Kinds¹, Anne C. A. Marijnissen¹, Max A. Viergever², P.J. Emans³, J.W.J. Bijlsma¹, F.P.J.G. Lafeber¹ and P.M.J. Welsing⁴, ¹Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ²Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands, ³Orthopaedic Surgery, Maastricht University Medical Center, Maastricht, Netherlands, ⁴Rheumatology & Clinical Immunology, F02.127, University Medical Center Utrecht, Utrecht, Netherlands
Background/Purpose: Osteoarthritis (OA) is a degenerative joint disease characterized by pain and functional disability. The expression of OA varies significantly between individuals and over time,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].